Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy
Publication Date: May 13, 2019
Last Updated: December 15, 2022
Diagnosis
Who to Study
For individuals and decedents with either a clinical or necropsy diagnosis of ACM, genetic testing of the established ACM-susceptibility genes is recommended. (I, C-EO)
573
For genetic testing of the established ACM-susceptibility genes, comprehensive analysis of all established genes with full coverage is recommended. (I, C-EO)
573
Treatment
Limitations of genetic testing
The interpretation of a cardiac genetic test by a team of providers with expertise in genetics and cardiology can be useful. (IIa, C-EO)
573
Title
Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy